Biotechnology

Found 8,688 articles

• 

  Chan Zuckerberg Initiative Continues to Grow, 250 Strong and More Expansion Coming

  9/20/2018

  In 2015, Priscilla Chan, a physician, and her husband, Facebook founder and CEO Mark Zuckerberg, created the Chan Zuckerberg Initiative (CZI). CZI’s stated goal was resoundingly ambitious.
• 

  Not Just Pocket Change: China's Hillhouse Capital's New Fund Has $10.6 Billion to Invest

  9/20/2018

  China’s Hillhouse Capital Group, an equity investment firm, has a new fund, Hillhouse Fund IV, with $10.6 billion ready to invest.
• 

  LineaRx to Collaborate with Italian Companies Takis and Evvivax on Cancer Vaccines

  9/20/2018

  LineaRx, a subsidiary of Applied DNA Sciences, has entered into a Joint Development Agreement with Takis SRL and Evvivax SLR. They will focus on developing anti-cancer vaccines.

• Celltrion Signs 'Incubation' Agreement with Emory University for Development of New Drugs for Atherosclerosis

  9/20/2018

  Research on new mechanisms to prevent ischemic heart disease and stroke, the leading causes of death in the world

• Cardurion Pharmaceuticals Announces Initiation of Phase 1 Study of CRD-733, a PDE-9 Inhibitor in Development for the Treatment of Heart Failure

  9/20/2018

  Cardurion Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug Application (IND) for CRD-733

• Early Access to IsoPlexis' Single Cell Analytics Platform Enhances Cell Therapy Program at World-renowned Research and Treatment Center

  9/20/2018

  IsoPlexis' groundbreaking platform has been shown in key studies to predict patient response to cell therapy

• First-Ever Rapid Response Test for Levels of Bifidobacterium in Baby's Gut Microbiome

  9/20/2018

  Evivo Stool Test Prototype Provides Clear Window into Infant Gut Health

• AGC Biologics Adds Mammalian Production Capacity in Japan

  9/20/2018

  New facility will include comprehensive mammalian process development and manufacturing capabilities

• Intec Pharma to Participate at Upcoming Investment Conferences

  9/20/2018

  Intec Pharma Ltd. today announces that Company management will participate at the following upcoming investment conferences.

• Compugen Announces Clinical Milestone Payment in Cancer Immunotherapy Collaboration With Bayer Following Dosing of First Patient in BAY 1905254 Phase 1 Trial

  9/20/2018

  Compugen entitled to $7.8 million milestone payment

• Merrimack Receives $5 Million Milestone Payment from Shire

  9/20/2018

  Merrimack Pharmaceuticals, Inc. today announced that it has received a $5 million milestone payment from Shire, triggered by the sale of ONIVYDE in the first major non-European, non-Asian country, pursuant to the terms of Merrimack's asset sale to Ipsen in 2017.

• Mylan and Fujifilm Kyowa Kirin Biologics Receive European Marketing Authorization for Hulio®, Biosimilar Adalimumab

  9/20/2018

  Mylan N.V. and Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for Hulio® (Product Code: FKB327), a biosimilar to AbbVie's Humira® (adalimumab), for all indications.

• Exicure Announces Positive Phase 1 Results for its Lead Immuno-Oncology Asset

  9/20/2018

  First in human results demonstrate potent immune system activation with no serious adverse events or dose limiting toxicity

• Puma Biotechnology to Present at 2018 Cantor Global Healthcare Conference

  9/20/2018

  Puma Biotechnology, Inc. announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 1:10 p.m. EDT on Monday, October 1, at the Cantor Global Healthcare Conference.

• VAXIMM Announces Regional Development and Commercialization Agreement with China Medical System Holdings

  9/20/2018

  CMS gains exclusive rights to current VAXIMM pipeline and option for future programs for China and other Asian countries, ex-Japan

• Revance Receives Great Place to Work Certification

  9/20/2018

  Revance Therapeutics, Inc. today announced that the company was certified as a great workplace this month by the independent analysts at Great Place to Work®.

• Ingenza takes a stake in new spin-out company Amprologix

  9/20/2018

  Ingenza is pleased to announce that it has become a stakeholder in Amprologix, a spin-out company from the University of Plymouth.

• Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders

  9/20/2018

  License with Nationwide Children’s Hospital (NCH) through the Acquisition of Celenex (NCH Spinout)

• Numab Appoints Immunotherapy Pioneer Ignacio Melero as Scientific Advisor

  9/20/2018

  Company progresses development of tri-specific IO therapeutic ND021

• Merck Receives Positive CHMP Opinion for DELSTRIGO™ (doravirine/lamivudine/tenofovir disoproxil fumarate) and PIFELTRO™ (doravirine) in the European Union for the Treatment of HIV-1 Infection

  9/20/2018

  Merck today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending granting of marketing authorization for two HIV-1 medicines: DELSTRIGO™